课题基金 / 基金详情

Mount Sinai Collaboration for Advancing Pediatric Quality Measures

Mount Sinai Collaboration for Advancing Pediatric Quality Measures
西奈山合作推进儿科质量措施
批准号:
8232537
负责人:
Lawrence C Kleinman
金额:
$198.2万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-03-01 至 2015-02-28

项目摘要

项目成果

Lawrence C Kleinman的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):西奈山医学院合作推进儿科质量测量(CAPQuaM)儿科质量测量对于负责任的医疗保健至关重要。尽管取得了很大进展,但衡量标准仍然面临巨大挑战。儿科质量衡量方案创建了一个国家基础设施来制定儿科质量衡量标准。我们聚集了国家和地区领导人,如西奈山推进儿科质量测量协作(CAPQuaM),以应对这些挑战,开发和增强儿科质量测量,并大幅推进美国儿科质量测量的方法和能力。我们提供以下三个广泛目标:具体目标1:部署我们的联合体作为具有广度和深度的专业知识的卓越中心,以开发和增强儿科质量指标,优化数据的有意义的使用,并可推广到公共和私营部门以及各种护理环境。我们以临床为导向的概念框架,我们提出的透明和包容的过程,以及我们对有意义的测量的承诺,将促进各州、卫生计划和医院采用这些措施。具体目标2:制定和加强儿科质量措施,通过处理CHIPRA和/或FOA中描述的五个优先事项来说明我们的能力:1)围产期护理;2)住院护理;3)精神/行为健康;4)护理协调;以及5)纠正或改善慢性身体状况的影响,从而在门诊环境中进行医疗保健。可能的任务和范例项目包括:1)开发一种评估早产儿使用表面活性物质的新方法;2)加强现有的评估行为/精神健康入院出院后门诊环境中护理协调情况的方法;以及3)开发一种新的方法来评估对复发性和/或持续性(慢性)中耳炎儿童手术干预的使用;具体目标3:开发创新方法以加强四个广泛领域的测量开发:(1)提高现有共识方法的有效性、可靠性和以患者为中心,在科学尚未确定和/或特别受患者偏好影响的关键临床领域推进测量设计;(2)在测量和电子测量的设计中纳入消费者和用户价值和观点的有意义的整合;(3)概念化和设计标准化、可行和可接受的电子数据捕获策略;(4)加强对不同分析单位的业绩衡量进行汇总和分层的方法,包括将业绩在单一人口或不同人口中的分布纳入对质量衡量的解释和评分的能力。CAPQuaM预计在四年内利用我们的三个阶段、3600个衡量标准的开发和测试过程开发或增强六个或更多的儿科质量衡量标准。管理和维护将伴随着发展。 公共卫生相关性:西奈山推进儿科质量测量合作(CAPQuaM)将领先的州、支付者、临床医生、家庭和其他利益相关者聚集在一起,提供必要的内容、科学和应用专业知识,以有效地应对AHRQ将提出的优先儿科质量测量任务。
英文摘要
DESCRIPTION (provided by applicant): Mount Sinai Medical School Collaboration for Advancing Pediatric Quality Measures (CAPQuaM) Pediatric quality measurement is essential for accountable health care. Despite much progress, substantial measurement challenges remain. The Pediatric Quality Measures Program creates a national infrastructure to develop pediatric quality measures. We bring together national and regional leaders as the Mount Sinai Collaboration for Advancing Pediatric Quality Measures (CAPQuaM) to address these challenges, to develop and enhance pediatric quality measures, and to advance substantially methods and capacity for pediatric quality measurement in the US. We offer the following three broad aims: Specific Aim 1: Deploy our consortium as a Center of Excellence with the breadth and depth of expertise to develop and enhance pediatric quality measures that optimize meaningful use of data and that can be generalized to both the public and private sector and across settings of care. Our clinically oriented conceptual framework, the transparent and inclusive process that we propose, and our commitment to meaningful measurement will promote adoption of these measures by states, health plans, and hospitals alike. Specific Aim 2: Develop and enhance pediatric quality measures, illustrating our capacity by addressing five of the priorities described in CHIPRA and/or the FOA: 1) perinatal care; 2) inpatient care; 3) mental/behavioral health; 4) coordination of care; and, 5) treatments to correct or ameliorate the effects of a chronic physical condition that leads to health care in the ambulatory setting. Possible assignments and example projects include: 1) Develop a new measure to assess the use of surfactant for premature infants; 2) Enhance the existing measure that assesses the coordination of care in the ambulatory setting after discharge from a behavioral/mental health admission; and 3) Develop a new measure that assesses the use of surgical intervention for children with recurrent and/or persistent (chronic) otitis media; Specific Aim 3: Develop innovative methods to enhance measure development in four broad areas: (1) Enhance the validity, reliability , and patient-centeredness of an existing consensus method, advancing measure design in critical clinical areas with unsettled science and/or that are especially subject to patient preferences; (2) Incorporate into this method meaningful integration of consumer and user values and perspectives in the design of measures and eMeasures; (3) Conceptualize and design of standardized, feasible and acceptable electronic data capture strategies; (4) Enhance methods for aggregating and stratifying performance measures across diverse units of analysis, including capacities to incorporate the distribution of performance across a single population or different populations into the interpretation and scoring of quality measures. CAPQuaM expects to develop or enhance six or more pediatric quality measures in four years using our three stage, 3600 measure development and testing process. Stewardship and maintenance will follow development. PUBLIC HEALTH RELEVANCE: The Mount Sinai Collaboration for Advancing Pediatric Quality Measures (CAPQuaM) brings together leading state, payer, clinician, family and other stakeholders with the required content, scientific and applied expertise to respond efficiently to priority pediatric quality measurement assignments as will be set forth by AHRQ.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Epidemiology, Exploration and Evaluation: Addressing potentially dangerous medications in Medicaid children with a mental health diagnosis
  • 批准号:
    9353754
  • 项目类别:
  • 资助金额:
    $49.72万
  • 财政年份:
    2015
  • 负责人:
    Lawrence C Kleinman
  • 依托单位:
Pediatric Quality Improvement Methods, Research and Evaluation Conference, Advanc
  • 批准号:
    8313171
  • 项目类别:
  • 资助金额:
    $4.99万
  • 财政年份:
    2012
  • 负责人:
    Lawrence C Kleinman
  • 依托单位:
Mount Sinai Collaboration for Advancing Pediatric Quality Measures
Mount Sinai Collaboration for Advancing Pediatric Quality Measures
海外基金